Global veterinary generics market is anticipated to offer potential growth opportunities for the market players over the forecast period.Rapid evolutions of generic molecules with similar therapeutic activity, the cost-effectiveness of the products are enabling to attract the customers towards the veterinary generics. The active pharmaceutical ingredient (API) of the generic molecule must be bioequivalent to the patented product. Veterinary pharma companies are focused on production generic molecules in order to meet the unmet need in the market. Increased adoption of small animals such as dogs and cats are trending from the past few years. The rise in the prevalence of various diseases like osteoarthritis (OA), chronic cancer pain, inflammation, other skin allergies are expected create demand for veterinary generics market. The generic products have cost less than the branded products, so the cost of the treatment will reduce. This enables greater margin on the farm with same desired effects and ensures good welfare standards. The introduction of generic products able to increase the competition within the market for that active ingredient, less cost of the product making it more affordable to the end user. Increased veterinary hospitals and clinics to offer better services small animals as well as farm animals anticipated to witness significant growth in veterinary generics market. Introduction of new generic drugs to treat chronic and acute pain, inflammation, other diseases are creating healthy growth opportunities. Rise in mergers & acquisitions to offer affordable products, is able to offer novel analgesics to the market. Increased awareness among the veterinary specialists and introduction of generic drugs are anticipated to create lucrative opportunities over the forecast period.